Head-to-head · WeighScore
EverFit Medical vs Get Thin MD
The verdict
Get Thin MD takes it — 66.7/100 to 58/100.
Get Thin MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Get Thin MD is a nationwide async telehealth platform offering compounded semaglutide and tirzepatide injections plus brand-name Ozempic and Zepbound where appropriate, alongside a broader wellness menu…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | EverFit Medical | Get Thin MD |
|---|---|---|
| WeighScore | 58/100 | 66.7/100 |
| Grade | C | C |
| Scorecard rank | #382 | #179 |
| Semaglutide | Not disclosed | $199/mo (compounded) |
| Tirzepatide | Not disclosed | $299/mo (compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #382 · C
Strengths
- Named owner publicly disclosed (Carrie Zatelli) — uncommon in this segment
- Physical clinic address published (Macedonia, Ohio)
- Direct phone and email published for human contact
- Hybrid model: Ohio in-person clinic for body scans and red-light therapy plus 50-state telehealth
- Plan includes evaluation, treatment plan, medication when appropriate, and optional nutrition coaching
Where it loses points
- Conflicting scope: hero claims all 50 states, but footer says services are Ohio-only — the 50-state track runs through partner group Dr Telx
- Pricing not published — gated behind a phone assessment
- Owner's clinical credentials (PA, RN, MD?) not stated
- Telehealth patients are treated by partner group Dr Telx, not EverFit itself — relationship isn't fully transparent
- No LegitScript or NABP .pharmacy seal displayed
Graded #179 · C
Strengths
- 3-month compounded semaglutide at $169/mo is among the lowest ongoing prices in the category
- Price-lock promise — same price every dose, no hidden fees
- Both compounded and brand-name options on one platform (sema, tirz, plus Ozempic and Zepbound)
- Nationwide availability with async evaluation — no in-person visit
- Broader wellness menu (sermorelin, NAD+, HRT, hair loss) lets you consolidate protocols
Where it loses points
- Compounded medications aren't FDA-approved and lack the review of brand-name GLP-1s
- Pharmacy partners not named — no way to verify the compounding source or batch testing
- Claims nationwide coverage but publishes no state list — confirm at intake
- Headline results (9.6 lbs in 30 days) come from self-reported patient data, not a trial
- Wide wellness funnel may steer you toward non-weight-loss protocols
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.